BioMarin Pharmaceutical Inc.

DB:BM8 Stock Report

Market Cap: €11.9b

BioMarin Pharmaceutical Future Growth

Future criteria checks 4/6

BioMarin Pharmaceutical is forecast to grow earnings and revenue by 27.2% and 7.7% per annum respectively. EPS is expected to grow by 25.8% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

27.2%

Earnings growth rate

25.8%

EPS growth rate

Biotechs earnings growth42.7%
Revenue growth rate7.7%
Future return on equity11.9%
Analyst coverage

Good

Last updated25 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:BM8 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,39978796293723
12/31/20253,09958079482328
12/31/20242,81439765760729
9/30/20242,753322311415N/A
6/30/20242,588257223329N/A
3/31/20242,472205173280N/A
12/31/20232,41916852159N/A
9/30/20232,31114725139N/A
6/30/20232,23510034161N/A
3/31/20232,1737215147N/A
12/31/20222,096142148176N/A
9/30/20222,00884151180N/A
6/30/20221,91254106119N/A
3/31/20221,88039134146N/A
12/31/20211,846-64185305N/A
9/30/20211,84916165280N/A
6/30/20211,917837155269N/A
3/31/20211,84479592214N/A
12/31/20201,8608541585N/A
9/30/20201,86385275156N/A
6/30/20201,84712258140N/A
3/31/20201,805114388N/A
12/31/20191,704-24-9048N/A
9/30/20191,603-43-5940N/A
6/30/20191,533-110-11217N/A
3/31/20191,519-90-878N/A
12/31/20181,491-77-7420N/A
9/30/20181,496-125-12-15N/A
6/30/20181,439-125N/A-23N/A
3/31/20181,383-145N/A29N/A
12/31/20171,314-117N/A-9N/A
9/30/20171,255-156N/A-24N/A
6/30/20171,201-181N/A-72N/A
3/31/20171,184-563N/A-137N/A
12/31/20161,117-630N/A-228N/A
9/30/20161,045-471N/A-293N/A
6/30/2016974-524N/A-286N/A
3/31/2016924-187N/A-253N/A
12/31/2015890-172N/A-219N/A
9/30/2015892-310N/A-179N/A
6/30/2015859-212N/A-185N/A
3/31/2015801-163N/A-183N/A
12/31/2014749-134N/A-70N/A
9/30/2014666-126N/A-58N/A
6/30/2014627-187N/A-59N/A
3/31/2014572-175N/A-54N/A
12/31/2013548-176N/A-57N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BM8's forecast earnings growth (27.2% per year) is above the savings rate (1%).

Earnings vs Market: BM8's earnings (27.2% per year) are forecast to grow faster than the German market (20.9% per year).

High Growth Earnings: BM8's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BM8's revenue (7.7% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: BM8's revenue (7.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BM8's Return on Equity is forecast to be low in 3 years time (11.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y